Literature DB >> 9016562

Effects of variations in length of hammerhead ribozyme antisense arms upon the cleavage of longer RNA substrates.

M Sioud1.   

Abstract

The efficacy of intracellular binding of hammerhead ribozyme to its cleavage site in target RNA is a major requirement for its use as a therapeutic agent. Such efficacy can be influenced by several factors, such as the length of the ribozyme antisense arms and mRNA secondary structures. Analysis of various IL-2 hammerhead ribozymes having different antisense arms but directed to the same site predicts that the hammerhead ribozyme target site is present within a double-stranded region that is flanked by single-stranded loops. Extension of the low cleaving hammerhead ribozyme antisense arms by nucleotides that base pair with the single-stranded regions facilitated the hammerhead ribozyme binding to longer RNA substrates (e.g. mRNA). In addition, a correlation between the in vitro and intracellular results was also found. Thus, the present study would facilitate the design of hammerhead ribozymes directed against higher order structured sites. Further, it emphasises the importance of detailed structural investigations of hammerhead ribozyme full-length target RNAs.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9016562      PMCID: PMC146427          DOI: 10.1093/nar/25.2.333

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  24 in total

1.  Enhancement of ribozyme catalytic activity by a contiguous oligodeoxynucleotide (facilitator) and by 2'-O-methylation.

Authors:  J Goodchild
Journal:  Nucleic Acids Res       Date:  1992-09-11       Impact factor: 16.971

2.  Ribozymes as potential anti-HIV-1 therapeutic agents.

Authors:  N Sarver; E M Cantin; P S Chang; J A Zaia; P A Ladne; D A Stephens; J J Rossi
Journal:  Science       Date:  1990-03-09       Impact factor: 47.728

3.  Numbering system for the hammerhead.

Authors:  K J Hertel; A Pardi; O C Uhlenbeck; M Koizumi; E Ohtsuka; S Uesugi; R Cedergren; F Eckstein; W L Gerlach; R Hodgson
Journal:  Nucleic Acids Res       Date:  1992-06-25       Impact factor: 16.971

4.  Implications of ribozyme kinetics for targeting the cleavage of specific RNA molecules in vivo: more isn't always better.

Authors:  D Herschlag
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

5.  Simple RNA enzymes with new and highly specific endoribonuclease activities.

Authors:  J Haseloff; W L Gerlach
Journal:  Nature       Date:  1988-08-18       Impact factor: 49.962

6.  Specific gene suppression by engineered ribozymes in monkey cells.

Authors:  F H Cameron; P A Jennings
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

7.  Ribozyme modulation of lipopolysaccharide-induced tumor necrosis factor-alpha production by peritoneal cells in vitro and in vivo.

Authors:  M Sioud
Journal:  Eur J Immunol       Date:  1996-05       Impact factor: 5.532

8.  Prevention of human immunodeficiency virus type 1 integrase expression in Escherichia coli by a ribozyme.

Authors:  M Sioud; K Drlica
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

9.  Hammerhead ribozyme-mediated cleavage of the long terminal repeat RNA of human immunodeficiency virus type 1.

Authors:  O Heidenreich; F Eckstein
Journal:  J Biol Chem       Date:  1992-01-25       Impact factor: 5.157

10.  Ribozyme mediated destruction of RNA in vivo.

Authors:  M Cotten; M L Birnstiel
Journal:  EMBO J       Date:  1989-12-01       Impact factor: 11.598

View more
  3 in total

1.  Inhibition of luciferase expression by synthetic hammerhead ribozymes and their cellular uptake.

Authors:  B Bramlage; S Alefelder; P Marschall; F Eckstein
Journal:  Nucleic Acids Res       Date:  1999-08-01       Impact factor: 16.971

2.  Small, efficient hammerhead ribozymes.

Authors:  M J McCall; P Hendry; A A Mir; J Conaty; G Brown; T J Lockett
Journal:  Mol Biotechnol       Date:  2000-01       Impact factor: 2.695

3.  Design of a ribozyme targeting human telomerase reverse transcriptase and cloning of it's gene.

Authors:  Zhi-Ming Hao; Jin-Yan Luo; Jin Cheng; Quan-Yin Wang; Guang-Xiao Yang
Journal:  World J Gastroenterol       Date:  2003-01       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.